WASHINGTON — Monday’s patent win by Monsanto Co. is “generally positive” for the biotech industry in Maryland, a member of the state’s Life Sciences Advisory Board said.
Rachel King, who is also the CEO of Gaithersburg-based GlycoMimetics Inc., was mindful of the Supreme Court’s admonition not to read too much into its ruling that found a farmer had violated Monsanto’s patent on genetically modified soybeans by planting second-generation seeds.
Her company, a clinical-stage biotech that develops drugs for sickle cell disease and various cancers, will not be directly affected by the ruling, King said. But even so, she was encouraged that the holding was unanimous and that the court rejected the farmer’s argument based on the “self-replicating” nature of seeds.
“For people or companies that own patents on products that can be self-replicated — and that might include cell lines or seeds or software — I think this ruling is important because it supports the argument that self-replicating products can be protected,” King said.
If the case had gone the other way, “it could have had quite a negative impact on innovation, in those spheres in particular,” she said, she said.
The Supreme Court on Monday rejected the farmer’s argument that cheap soybeans he bought from a grain elevator are not covered by the Monsanto patents, even though most of them also were from plants that had been grown from seeds genetically modified to resist the company’s Roundup herbicide.
While Monsanto won this case, the court refused to make a sweeping decision that would cover other self-replicating technologies like DNA molecules and nanotechnologies, leaving that for another day. Businesses and researchers had been closely watching this case in hopes of getting guidance on patents, but Justice Elena Kagan said the court’s holding Monday only “addresses the situation before us.”
In a statement, Monsanto officials said they were pleased with the court’s ruling.
“The court’s ruling today ensures that longstanding principles of patent law apply to breakthrough 21st century technologies that are central to meeting the growing demands of our planet and its people,” said David F. Snively, Monsanto’s top lawyer. “The ruling also provides assurance to all inventors throughout the public and private sectors that they can and should continue to invest in innovation that feeds people, improves lives, creates jobs, and allows America to keep its competitive edge.”
In the case decided by the court, farmer Vernon Hugh Bowman bought expensive, patented Monsanto’s “Roundup Ready” seeds for his main crop of soybeans, but decided to look for something cheaper for a risky, late-season soybean planting. He went to a grain elevator that held soybeans it typically sells for feed, milling and other uses, but not as seed.
Bowman reasoned that most of those soybeans also would be resistant to weed killers, as the plants they came from were grown from herbicide-resistant seeds. He was right, and he bought soybeans from the grain elevator and planted them over eight years. In 2007, Monsanto sued and won an $84,456 judgment.
Monsanto has a policy to protect its investment in seed development that prohibits farmers from saving or reusing the seeds once the crop is grown. Farmers must buy new seeds every year. More than 90 percent of American soybean farms use Monsanto’s seeds, which first came on the market in 1996.
Don’t blame the bean
Bowman’s lawyers argued that Monsanto’s patent rights stopped with the sale of the first crop of beans instead of extending to each new crop soybean farmers grow that has the gene modification that allows it to withstand the application of weed-killer.
But Kagan disagreed. “Bowman planted Monsanto’s patented soybeans solely to make and market replicas of them, thus depriving the company of the reward patent law provides for the sale of each article,” she said. “Patent exhaustion provides no haven for such conduct.”
Bowman also said he should not be liable, in part, because soybeans naturally sprout when planted.
Kagan said the court also did not buy that argument. “We think the blame-the-bean defense tough to credit,” she said.
Andrew Kimbrell, executive director of Center for Food Safety, said the ruling was wrong. “The court chose to protect Monsanto over farmers,” Kimbrell said. “The court’s ruling is contrary to logic and to agronomics, because it improperly attributes seeds’ reproduction to farmers, rather than nature.”
But a soybean growers’ association said it was the correct decision. “The Supreme Court has ensured that America’s soybean farmers, of which Mr. Bowman is one, can continue to rely on the technological innovation that has pushed American agriculture to the forefront of the effort to feed a global population projected to pass 9 billion by 2050,” said Danny Murphy, president of the American Soybean Association.
Calls to Bowman by The Associated Press were unanswered.
In other decisions Monday, the court:
— unanimously held that use of the bankruptcy term “defalcation” requires an intentional wrong. This came in a case where an Illinois man took improper loans from his father’s trust, the first at his father’s direction.
— unanimously held that federal law does not pre-empt a state law claim against a New Hampshire towing company that towed, stored and then disposed of a car owned by a man who was seriously ill in a hospital.
The soybean case is Bowman v. Monsanto Co., 11-796.
Alissa Gulin of The Daily Record contributed to this article.